Recordati is acquiring Sanofi’s Enjaymo, the only approved drug for the rare blood disorder cold agglutinin disease. Achieving sales milestones could bring the deal’s value to more than $1 ...

Cold Agglutinin Disease (CAD) is a type of autoimmune hemolytic anemia characterized by the presence of cold agglutinins—antibodies that cause red blood cells to clump together at lower ...

The direct antiglobulin test was positive for anti-C3d specificity, with cold agglutinin titer confirming the diagnosis of CAD.

LAS VEGAS , NV, UNITED STATES, January 27, 2025 /EINPresswire / -- DelveInsight's“Cold Agglutinin disease Market Insight, Epidemiology And Market Forecast - 2034′′ report offers an in-depth ...

(MENAFN- EIN Presswire) DelveInsight's Cold Agglutinin disease market Report provides comprehensive insights into the epidemiology and market dynamics across the 7MM. LAS VEGAS , NV, UNITED STATES ...

Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD ... It causes anaemia as well as other symptoms like fatigue and light-headedness, and in some cases patients ...